TREM2, Microglia, and Neurodegenerative Diseases

Trends in Molecular Medicine
Felix L YehMorgan Sheng

Abstract

Alzheimer's disease (AD) is the most common form of dementia and the 6th leading cause of death in the US. The neuropathological hallmarks of the disease are extracellular amyloid-β (Aβ) plaques and intraneuronal hyperphosphorylated tau aggregates. Genetic variants of TREM2 (triggering receptor expressed on myeloid cells 2), a cell-surface receptor expressed selectively in myeloid cells, greatly increase the risk of AD, implicating microglia and the innate immune system as pivotal factors in AD pathogenesis. Recent studies have advanced our understanding of TREM2 biology and microglial activities in aging and neurodegenerative brains, providing new insights into TREM2 functions in amyloid plaque maintenance, microglial envelopment of plaque, microglia viability, and the identification of novel TREM2 ligands. Our increased understanding of TREM2 and microglia has opened new avenues for therapeutic intervention to delay or prevent the progression of AD.

Citations

Jan 25, 2018·International Journal of Molecular Sciences·Carmen MeccaCataldo Arcuri
Mar 21, 2018·Nature Neuroscience·Robert A HillJaime Grutzendler
May 3, 2018·Critical Reviews in Biochemistry and Molecular Biology·Angela JeongLing Li
Jan 13, 2018·The Journal of Experimental Medicine·Wilbur M SongMarco Colonna
Sep 24, 2017·Journal of Neurochemistry·Jochen WalterKonstantin Glebov
Sep 30, 2017·Expert Opinion on Therapeutic Targets·Elena MarcelloMonica Di Luca
Dec 21, 2017·Intractable & Rare Diseases Research·Jun-Ichi SatohYuko Saito
Jan 11, 2018·Developmental Neurobiology·Xiaoliang ZhaoLong-Jun Wu
Aug 18, 2018·Nature Reviews. Drug Discovery·Barry BolandMark J Millan
Aug 30, 2018·Physiological Reviews·Vanessa Frodermann, Matthias Nahrendorf
Dec 3, 2017·The Journal of Cell Biology·David V HansenMorgan Sheng
Nov 18, 2018·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Sarah R Anderson, Monica L Vetter
Feb 26, 2019·Current Protocols in Pharmacology·Kevin Mullane, Michael Williams
Aug 3, 2019·The EMBO Journal·Vassilis StratouliasBertrand Joseph
Oct 21, 2018·EMBO Molecular Medicine·Christian B LessardTodd E Golde
Aug 5, 2017·Molecular Neurodegeneration·Taylor R JayGary E Landreth
Dec 12, 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yukari Shigemoto-Mogami, Kaoru Sato
Sep 4, 2019·Journal of Neurochemistry·Dafina M Angelova, David R Brown
May 29, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Jared T HinkleTed M Dawson
Sep 5, 2019·Current Alzheimer Research·Anurag K SinghSantosh Kumar Singh
Apr 3, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dennis Kristopher BernerChristoph Becker-Pauly
Jun 4, 2020·Journal of Neurovirology·Audrey C KnightJoseph L Mankowski
Dec 19, 2019·The International Journal of Neuroscience·Qian WangYueran Zhao
Jul 3, 2020·Investigative Ophthalmology & Visual Science·Milica A MargetaNEIGHBORHOOD consortium
Feb 1, 2020·Current Neuropharmacology·Sara MerloMaria Angela Sortino
Jul 1, 2020·Neuropathology and Applied Neurobiology·B A AshfordJ R Highley
Mar 23, 2018·Journal of Alzheimer's Disease : JAD·Eleanor DrummondThomas Wisniewski
Jun 6, 2018·Frontiers in Aging Neuroscience·Victoria NavarroJavier Vitorica
Jun 28, 2018·Molecular Neurobiology·Min-Jung ParkMin-Soo Kwon
Feb 23, 2019·Journal of Neuroinflammation·Kaja NordengenTormod Fladby
Apr 6, 2019·Science·Adriana M Mujal, Matthew F Krummel
Sep 5, 2019·International Journal of Molecular Sciences·Verica VasicMirko H H Schmidt
Jun 30, 2018·International Journal of Molecular Sciences·Barbara MroczkoPiotr Lewczuk
Aug 22, 2018·Frontiers in Cellular Neuroscience·Hiroyuki Konishi, Hiroshi Kiyama
Aug 25, 2018·Nature Reviews. Immunology·Yang Shi, David M Holtzman
Nov 30, 2018·Frontiers in Cellular Neuroscience·Carmen Romero-MolinaMarisa Vizuete
Dec 23, 2018·Molecular Neurodegeneration·Maud GratuzeDavid M Holtzman
Dec 12, 2018·Frontiers in Aging Neuroscience·Honghua ZhengYun-Wu Zhang
Dec 14, 2019·Alzheimer's Research & Therapy·Daria BortolottiRoberta Rizzo
Oct 28, 2019·Frontiers in Cellular Neuroscience·Hailan YaoDaniel Paris
Jan 8, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simone BrioschiMarco Colonna
Sep 17, 2020·International Journal of Molecular Sciences·Eunyoung KimSang Seong Kim
Aug 11, 2020·Tremor and Other Hyperkinetic Movements·Vasileios SiokasEfthimios Dardiotis
Sep 29, 2020·Frontiers in Neuroscience·María Teresa Flores-DorantesRuth Gutiérrez-Aguilar
Jan 9, 2019·Frontiers in Cellular Neuroscience·Sara BachillerAntonio Boza-Serrano
May 1, 2019·Proceedings of the National Academy of Sciences of the United States of America·Takayuki InoueNoriko Satoh-Asahara
Jul 31, 2019·Scientific Reports·Emma K EricksonR Dayne Mayfield
Jul 21, 2019·Nature Reviews. Neurology·Fiona BrightJillian J Kril
Sep 14, 2019·Annual Review of Genetics·Christopher J BohlenMorgan Sheng
Jul 9, 2020·Journal of Neuroinflammation·Jiaolong YangZhentao Zhang
Apr 8, 2020·Journal of Immunology Research·M A F YahayaM Z Mehat
May 7, 2020·International Journal of Molecular Sciences·Andrea Crespo-Castrillo, Maria-Angeles Arevalo
Aug 10, 2018·Frontiers in Neuroscience·Jacqueline P RobbinsSimon Lovestone
Jun 20, 2019·Frontiers in Immunology·Luke W BonhamJennifer S Yokoyama
Jul 24, 2019·Journal of Neuroinflammation·Penelope J HallettOle Isacson
Aug 30, 2020·Neural Regeneration Research·Yu XuWei-Lin Jin
Aug 12, 2020·JCI Insight·Smadar GoldfarbTamir Ben-Hur
Sep 26, 2020·Frontiers in Molecular Neuroscience·Emily J Koller, Paramita Chakrabarty
Mar 23, 2018·Journal of Alzheimer's Disease : JAD·Antonia Gutierrez, Javier Vitorica
Sep 18, 2020·Immunology·Falguni BaidyaPallab Bhattacharya
Oct 24, 2020·Scientific Reports·Motoaki YanaizuYoshihiro Kino
Oct 23, 2020·Nuclear Medicine and Molecular Imaging·Dong Soo LeeYoori Choi
Nov 3, 2020·Frontiers in Aging Neuroscience·Feiqi ZhuJie Zhu
Dec 20, 2020·International Journal of Molecular Sciences·You Jung KangHansang Cho
Feb 24, 2021·Glia·Dave E MarzanJames L Salzer
Feb 10, 2021·Current Opinion in Neurology·Ana Griciuc, Rudolph E Tanzi
Feb 26, 2021·Nature Communications·Alessio ColomboSabina Tahirovic
Aug 28, 2020·Neurochemistry International·Dia AdvaniPravir Kumar
Jul 20, 2020·Ageing Research Reviews·Amalia C BruniCarlo Gabelli
Apr 9, 2021·The Application of Clinical Genetics·Daniel W SirkisJennifer S Yokoyama
Mar 31, 2021·The European Journal of Neuroscience·Sadat ShafiFaheem Hyder Pottoo
Apr 28, 2021·Annual Review of Immunology·Nehemiah CoxFrederic Geissmann

Related Concepts

Related Feeds

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Related Papers

Biomolecular Concepts
Marta BolósJesús Avila
The New England Journal of Medicine
Rita GuerreiroAlzheimer Genetic Analysis Group
Trends in Molecular Medicine
Frank M LaFerla, Salvatore Oddo
© 2021 Meta ULC. All rights reserved